P8IP
IBB icon

Pier 88 Investment Partners’s iShares Biotechnology ETF IBB Stock Holding History

Pier 88 Investment Partners’s Portfolio IBB Stock Details IBB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-5,400
Closed -$651K – 99
2019
Q4 		$651K Buy
+5,400
New +$602K 0.26% 54

Other funds holding IBB

Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $521B AUM 51.41% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $289B AUM 60.46% 1-Year Est. Return
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund Toronto, Ontario, Canada $71.2B AUM 48.86% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Pier 88 Investment Partners's IBB Position: Q1 2020 in Review

Pier 88 Investment Partners sold out of iShares Biotechnology ETF (IBB) in Q1 2020, closing a stake of 5,400 shares — an estimated $651K sold.

Pier 88 Investment Partners first reported a position in IBB in Q4 2019 and held it in 1 quarter. The position peaked at $651K in Q4 2019. 666 funds tracked by Wall St. Rank hold IBB as of Q1 2020.

  • Pier 88 Investment Partners reported no remaining iShares Biotechnology ETF position as of Q1 2020 after selling out during the quarter.
  • Pier 88 Investment Partners sold 5,400 iShares Biotechnology ETF shares in Q1 2020, an estimated $651K.
  • Pier 88 Investment Partners first reported a position in iShares Biotechnology ETF in Q4 2019 and held it in 1 quarter.
  • Pier 88 Investment Partners's iShares Biotechnology ETF position peaked at $651K in Q4 2019.
  • 666 funds tracked by Wall St. Rank held iShares Biotechnology ETF as of Q1 2020.

Based on Pier 88 Investment Partners's 13F filing for Q1 2020, filed 15 May 2020.